RATIONALE: Protein kinase (PK)C-induced phosphorylation of cardiac troponin (cTn)I has been shown to regulate cardiac contraction. OBJECTIVE: Characterize functional effects of increased PKC-induced cTnI phosphorylation and identify underlying mechanisms using a transgenic mouse model (cTnI(PKC-P)) expressing mutant cTnI (S43E, S45E, T144E). METHODS AND RESULTS: Two-dimensional gel analysis showed 7.2+/-0.5% replacement of endogenous cTnI with the mutant form. Experiments included: mechanical measurements (perfused isolated hearts, isolated papillary muscles, and skinned fiber preparations), biochemical and molecular biological measurements, and a mathematical model-based analysis for integrative interpretation. Compared to wild-type mice, cTnI(PKC-P) mice exhibited negative inotropy in isolated hearts (14% decrease in peak developed pressure), papillary muscles (53% decrease in maximum developed force), and skinned fibers (14% decrease in maximally activated force, F(max)). Additionally, cTnI(PKC-P) mice exhibited slowed relaxation in both isolated hearts and intact papillary muscles. The cTnI(PKC-P) mice showed no differences in calcium sensitivity, cooperativity, steady-state force-MgATPase relationship, calcium transient (amplitude and relaxation), or baseline phosphorylation of other myofilamental proteins. The model-based analysis revealed that experimental observations in cTnI(PKC-P) mice could be reproduced by 2 simultaneous perturbations: a decrease in the rate of cross-bridge formation and an increase in calcium-independent persistence of the myofilament active state. CONCLUSIONS: A modest increase in PKC-induced cTnI phosphorylation ( approximately 7%) can significantly alter cardiac muscle contraction: negative inotropy via decreased cross-bridge formation and negative lusitropy via persistence of myofilament active state. Based on our data and data from the literature we speculate that effects of PKC-mediated cTnI phosphorylation are site-specific (S43/S45 versus T144).
RATIONALE: Protein kinase (PK)C-induced phosphorylation of cardiac troponin (cTn)I has been shown to regulate cardiac contraction. OBJECTIVE: Characterize functional effects of increased PKC-induced cTnI phosphorylation and identify underlying mechanisms using a transgenicmouse model (cTnI(PKC-P)) expressing mutant cTnI (S43E, S45E, T144E). METHODS AND RESULTS: Two-dimensional gel analysis showed 7.2+/-0.5% replacement of endogenous cTnI with the mutant form. Experiments included: mechanical measurements (perfused isolated hearts, isolated papillary muscles, and skinned fiber preparations), biochemical and molecular biological measurements, and a mathematical model-based analysis for integrative interpretation. Compared to wild-type mice, cTnI(PKC-P) mice exhibited negative inotropy in isolated hearts (14% decrease in peak developed pressure), papillary muscles (53% decrease in maximum developed force), and skinned fibers (14% decrease in maximally activated force, F(max)). Additionally, cTnI(PKC-P) mice exhibited slowed relaxation in both isolated hearts and intact papillary muscles. The cTnI(PKC-P) mice showed no differences in calcium sensitivity, cooperativity, steady-state force-MgATPase relationship, calcium transient (amplitude and relaxation), or baseline phosphorylation of other myofilamental proteins. The model-based analysis revealed that experimental observations in cTnI(PKC-P) mice could be reproduced by 2 simultaneous perturbations: a decrease in the rate of cross-bridge formation and an increase in calcium-independent persistence of the myofilament active state. CONCLUSIONS: A modest increase in PKC-induced cTnI phosphorylation ( approximately 7%) can significantly alter cardiac muscle contraction: negative inotropy via decreased cross-bridge formation and negative lusitropy via persistence of myofilament active state. Based on our data and data from the literature we speculate that effects of PKC-mediated cTnI phosphorylation are site-specific (S43/S45 versus T144).
Authors: G A MacGowan; C Du; D B Cowan; C Stamm; F X McGowan; R J Solaro; A P Koretsky; P J Del Nido Journal: Am J Physiol Heart Circ Physiol Date: 2001-02 Impact factor: 4.733
Authors: Samhita S Rhodes; Kristina M Ropella; Said H Audi; Amadou K S Camara; Leo G Kevin; Paul S Pagel; David F Stowe Journal: Am J Physiol Heart Circ Physiol Date: 2002-12-12 Impact factor: 4.733
Authors: Guy A MacGowan; Caroline Evans; Tom C-C Hu; Dan Debrah; Steven Mullet; Hsiao-Huei Chen; Charles F McTiernan; Alexandre F R Stewart; Alan P Koretsky; Sanjeev G Shroff Journal: Cardiovasc Res Date: 2004-08-01 Impact factor: 10.787
Authors: Brian B Roman; Paul H Goldspink; Elyse Spaite; Dalia Urboniene; Ron McKinney; David L Geenen; R John Solaro; Peter M Buttrick Journal: Am J Physiol Heart Circ Physiol Date: 2004-01-15 Impact factor: 4.733
Authors: Eileen M Burkart; Marius P Sumandea; Tomoyoshi Kobayashi; Mahta Nili; Anne F Martin; Earl Homsher; R John Solaro Journal: J Biol Chem Date: 2003-01-27 Impact factor: 5.157
Authors: Benjamin R Nixon; Ariyoporn Thawornkaiwong; Janel Jin; Elizabeth A Brundage; Sean C Little; Jonathan P Davis; R John Solaro; Brandon J Biesiadecki Journal: J Biol Chem Date: 2012-04-06 Impact factor: 5.157
Authors: Mariah H Goodall; Robert D Wardlow; Rebecca R Goldblum; Andrew Ziman; W Jonathan Lederer; William Randall; Terry B Rogers Journal: J Biol Chem Date: 2010-11-01 Impact factor: 5.157
Authors: Dennis M Abraham; Robert T Davis; Chad M Warren; Lan Mao; Beata M Wolska; R John Solaro; Howard A Rockman Journal: Proc Natl Acad Sci U S A Date: 2016-11-28 Impact factor: 11.205
Authors: Sarah E Lang; Jennifer Schwank; Tamara K Stevenson; Mark A Jensen; Margaret V Westfall Journal: J Mol Cell Cardiol Date: 2014-12-03 Impact factor: 5.000